BioMarin Pharmaceutical Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
BioMarin Pharmaceutical Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Novato
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BMRN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001048477
EIN
68-0397820
Wikidata ID
Q4914632

Board of directors

Follow this board

Chief executives

Alexander Hardy · Chief Executive Officer
Since December 2023
95 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 35% of the scoring weight is on file.

Revenue growth 20%
90

15.4% a year in revenue

Earnings growth 15%
100

33.9% a year in earnings per share

35% of the scoring weight is on file. Figures cover December 2022 – December 2025.

Jean Jacques Bienaime · Chief Executive Officer
2005 – 2023 · Former

Director election results

Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

14 of this board's directors also sit on 38 other boards. 36 are in the same sector.

Network of BioMarin Pharmaceutical Inc.'s board connections Accuray Incorporated Accuray Incorporated Agios Pharmaceuticals Inc. Agios Pharmaceuticals... Alnylam Pharmaceuticals Inc. Alnylam Pharmaceutical... Ascendis Pharma A/S Ascendis Pharma A/S Century Therapeutics Inc. Century Therapeutics I... Charles River Laboratories International Inc. Charles River Laborato... Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals... Embecta Corp. Embecta Corp. Enovis Corporation Enovis Corporation Geron Corporation Geron Corporation GoodRx Holdings Inc. GoodRx Holdings Inc. Guardant Health Inc. Guardant Health Inc. Henry Schein Inc. Henry Schein Inc. Immunome Inc. Immunome Inc. Incyte Corp. Incyte Corp. Insmed Incorporated Insmed Incorporated Barbara W. Bodem Barbara W. Bodem David E. I. Pyott David E. I. Pyott Elizabeth M. Anderson Elizabeth M. Anderso... Ian T. Clark Ian T. Clark Jean Jacques Bienaime Jean Jacques Bienaim... Mark J. Enyedy Mark J. Enyedy Maykin Ho Maykin Ho Richard A. Meier Richard A. Meier Robert J. Hombach Robert J. Hombach Timothy P. Walbert Timothy P. Walbert BioMarin Pharmaceutical In...
Shared director Other board Same sector +22 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$4,318,170
5 sales by 3 insiders
Date Insider Transaction Shares Price Value
Sep 30, 2026 Friberg Gregory R Officer (EVP, Chief R&D Officer) Shares withheld for tax −4,086 $60.00 $245,160
Sep 10, 2026 Robert M. Plenge Director Grant or award +6,140 — —
Sep 2, 2026 Davis George Eric Officer (EVP, Chief Legal Officer) Open-market sale −17,557 $66.28 $1,163,678
Jun 2, 2026 Athena Countouriotis Director Grant or award +7,490 — —
Jun 2, 2026 Timothy P. Walbert Director Grant or award +7,490 — —
Jun 2, 2026 Maykin Ho Director Grant or award +7,490 — —
Jun 2, 2026 Robert J. Hombach Director Grant or award +7,490 — —
Jun 2, 2026 Mark J. Enyedy Director Grant or award +7,490 — —
Jun 2, 2026 Willard H. Dere Director Grant or award +7,490 — —
Jun 2, 2026 Ian T. Clark Director Grant or award +7,490 — —
Jun 2, 2026 Barbara W. Bodem Director Grant or award +7,490 — —
Jun 2, 2026 Elizabeth M. Anderson Director Grant or award +7,490 — —
May 20, 2026 Hubbard Cristin Officer (EVP, Chief Commercial Officer) Shares withheld for tax −2,318 $50.20 $116,364
May 7, 2026 Friberg Gregory R Officer (EVP, Chief R&D Officer) Open-market sale −3,281 $53.85 $176,682
Mar 18, 2026 Davis George Eric Officer (EVP, Chief Legal Officer) Shares withheld for tax −1,273 $56.05 $71,352

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States

Questions about BioMarin Pharmaceutical Inc.

Who is the CEO of BioMarin Pharmaceutical Inc.?

Alexander Hardy has been BioMarin Pharmaceutical Inc.'s Chief Executive Officer since December 2023.

How many directors are on BioMarin Pharmaceutical Inc.'s board?

BioMarin Pharmaceutical Inc.'s board has 18 directors: Alexander Hardy, Athena Countouriotis, Barbara W. Bodem, David E. I. Pyott, Dennis Slamon, Elaine J. Heron, Elizabeth M. Anderson, Ian T. Clark, Jean Jacques Bienaime, Mark J. Alles and 8 others.

Are BioMarin Pharmaceutical Inc. insiders buying or selling shares?

Over the last 12 months, BioMarin Pharmaceutical Inc. insiders made no open-market purchases and sold $4.3 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is BioMarin Pharmaceutical Inc. connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="biomarin-pharmaceutical-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.